Stockreport

Septerna to Participate in Upcoming Investor Conferences

Septerna, Inc.  (SEPN) 
PDF SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein- [Read more]